Comparison of two sublingual types of desmopressin in 6-year-old and more children with primary nocturnal enuresis. About an international randomized cross-over study;Comparaison de deux formes orales de desmopressine chez des enfants de six ans et plus souffrant d'énurésie nocturne primaire isolée. À propos d'une étude internationale randomisée en cross-over (PALAT)

Progres en Urologie

Volumn 19, Issue 2, 2009, Pages 132-138

  Lottmann, H ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Desmopressin; Incontinence; Nocturnal enuresis; Treatment

Indexed keywords

ANTIDIURETIC AGENT; ARGIPRESSIN[1 DEAMINO];

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; MALE; MULTICENTER STUDY; NOCTURNAL ENURESIS; PATIENT SATISFACTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ANTIDIURETIC AGENTS; CHILD; CROSS-OVER STUDIES; DEAMINO ARGININE VASOPRESSIN; FEMALE; HUMANS; MALE; NOCTURNAL ENURESIS; PATIENT SATISFACTION; PROSPECTIVE STUDIES;

EID: 58449090353     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2008.09.061     Document Type: Article

References (20)

1. Neveus T., von Gontard A., Hœbeke P., Hjalmas K., Bauer S., Bower W., et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the standardization committee of the International Children's Continence Society (ICCS). Neurourol Urodyn 26 (2007) 90-102
2. Hellstrom A.L., Hanson E., Hansson S., Hjalmas K., and Jodal U. Micturition habits and incontinence in 7-year-old Swedish school entrants. Eur J Pediatr 149 (1990) 434-437
3. Yeung C.K., Sreedhar B.I.J.I., Sihoe J.D.Y., Sit F.K.Y., and Lau J. Differences in characteristics of nocturnal enuresis between children and adolescents: a critical appraisal from a large epidemiological study. BJU Int 97 (2006) 1069-1073
4. Nappo S., Del Gado R., Chiozza M.L., Biraghi M., Ferrara P., and Caione P. Nocturnal enuresis in the adolescent: a neglected problem. BJU Int 90 (2002) 912-917
5. Butler R.J. Impact of nocturnal enuresis on children and young people. Scand J Urol Nephrol 35 (2001) 169-176
6. Lottmann H. Enuresis treatment in France. Scand J Urol Nephrol Suppl 202 (1999) 66-69
7. Averous M., and Lopez C. Bilan de 20 ans de réflexion sur l'énurésie de l'enfant. Prog Urol 7 (1997) 476-483
8. Aikawa T., Kasahara T., and Uchiyama M. The arginine-vasopressin secretion profile of children with primary nocturnal enuresis. Eur Urol 33 (1998) 41-44
9. Nijman R, Bower W, Ellsworth P, et al. Diagnosis and management of urinary incontinence and encopresis in childhood. In: Abrams P, Cardozo L, Khoury S, Wein A, eds. Incontinence, vol. 2. Pleymouth, MA: Health Publication Limited; 2005.p. 965-1057.
10. Rittig S., Knudsen U.B., Norgaard J.P., Pedersen E.B., and Djurhuus J.C. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol 256 (1989) 664-671
11. Neveus T., Lackgren G., Stenberg A., Tuvemo T., and Hetta J. Sleep and night-time behaviour of enuretics and non-enuretics. Br J Urol Suppl 81 (1998) 67-71
12. Yeung C.K., Sit F.K.Y., To L.C.K., Chiu H.N., Sihoe J.D.Y., Lee E., et al. Reduction in nocturnal functional bladder capacity is a common factor in the pathogenesis of refractory nocturnal enuresis. BJU Int 90 (2002) 302-307
13. Brink H.S., Derkx F.H.M., Boomsma F., and Schalekamp M.A.D.H. Effects of DDAVP on renal hemodynamics and renin secretion in subjects with essential hypertension. Clin Nephrol 42 (1994) 95-101
14. Devitt H., Holland P., Butler R., Redfern E., Hiley E., and Roberts G. Plasma vasopressin and response to treatment in primary nocturnal enuresis. Arch Dis Child 80 (1999) 448-451
15. Medel R., Dieguez S., Brindo M., Ayuso S., Canepa C., Ruarte A., et al. Monosymptomatic primary enuresis: differences between patients responding or not responding to oral desmopressin. BJU 81 (1998) 46-49
16. Standing J.F., and Tuleu C. Paediatric formulations-getting to the heart of the problem. Int J Pharm 300 (2005) 56-66
17. Committee For Medicinal Products For Human Use. Reflection Paper: formulations of Choice for the Paediatric Population. London 2006 EMEA/CHMP/PEG/194810/2005. Disponible à l'adresse: http://www.emea.europa.eu/pdfs/human/paediatrics/19481005en.pdf (consulté le 10 décembre 2007).
18. Osterberg O., Radojka M., Savic M.S., Karlson M.O., Simonsson U.S.H., Norgaard J.P., et al. Pharmacokinetics of desmopressin administred as an oral lyophilisate dosage from in children with primary nocturnal enuresis and healthy adults. J Clin Pharm 46 (2006) 1204-1211
19. Vande Walle J., Bogaert G.A., Mattsson S., Schurmans T., Hoebeke P., Deboe V., et al. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis. BJU Int 97 (2006) 603-609
20. Ferber R. Solve your child's sleep problems. lst ed (1985), Simon and Schuster, New York